InSpace™ System in Comparison to Best Repair of Massive Rotator Cuff Tear.

Sponsor
OrthoSpace Ltd. (Industry)
Overall Status
Terminated
CT.gov ID
NCT01890733
Collaborator
(none)
5
1
2
36
0.1

Study Details

Study Description

Brief Summary

This is a post-marketing study to further assess the safety and effectiveness of the InSpace™ device implantation in comparison to surgical repair of full thickness Massive Rotator Cuff Tear .

The effectiveness will be assessed by comparing the scores of the ASES, Constant and Quick DASH outcome questionnaires with respect to pain reduction, improvement of activity of daily living(ADL) and improvement of range of motion (ROM).

Condition or Disease Intervention/Treatment Phase
  • Device: Best Repair of torn Rotator Cuff
  • Device: InSpace™ system
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Randomized, Two-arm, Prospective, Subject Blind Study to Assess the Efficacy and Safety of InSpace™ Device in Comparison to Massive Rotator Cuff Repair in Subjects Scheduled for a Repair Surgery.
Study Start Date :
Sep 1, 2012
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Best Repair of torn Rotator Cuff

Subjects will undergo surgical intervention (usually arthroscopy) to perform debridment, acromioplasty if deemed necessary, long head of biceps tenotomy, and at least partial repair.

Device: Best Repair of torn Rotator Cuff

Active Comparator: InSpace™ system

Subjects will undergo surgical intervention (usually arthroscopy or mini invasive) of debridment, acromioplasty if deemed necessary with or without long head of biceps tenotomy, and placement of the InSpace™ system.

Device: InSpace™ system

Outcome Measures

Primary Outcome Measures

  1. Comparison of respose rate at each treatment arm [6m]

    The primary efficacy outcome of the study is considered as the subject response/rehabilitation rate at 6 month post implantation as assesed by the change in the Shoulder Score

Secondary Outcome Measures

  1. subjects requiring re-operation of the repaired tear at the end of the follow-up period. [24 m post implantation]

    Comparison of number of subjects requiring re-operation of the repaired tear at the end of the follow-up period at each tratment arm.

  2. change of total questionnaires scores from baseline to each follow-up visit. [6W, 3m, 6m , 12m ,24m]

    Comparison between the change of total questionnaires scores from baseline to each follow-up visit at each treatment arm.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Main Inclusion Criteria:
  • Age 40 or older.

  • Positive diagnostic imaging (CT arthrogram or MRI)* of the affected shoulder indicating full thickness Massive RCT of at least 5cm in diameter (according to Cofield classification) or long - narrow tears of at least 4cm2 (W>2cm and L>2cm) including fatty infiltration grade III or IV (according to classification of Goutallier) involving more than one tendon. - Persistent pain and functional disability of the affected shoulder for at least 3 months.

Main Exclusion Criteria :
  • Known allergy to the balloon material (copolymer of PLA and -θ-caprolactone).

  • Evidence of significant osteoarthritis or cartilage damage in the shoulder

  • Evidence of gleno-humeral instability

  • Previous surgery of the shoulder in the past 2 years, excluding diagnostic arthroscopy

  • Evidence of major joint trauma, infection, or necrosis in the shoulder

  • Partial-thickness tears of the rotator cuff

Contacts and Locations

Locations

Site City State Country Postal Code
1 Policlinico Milano Italy

Sponsors and Collaborators

  • OrthoSpace Ltd.

Investigators

  • Principal Investigator: Luigi Solimeno, MD, Policlinico de Milano

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
OrthoSpace Ltd.
ClinicalTrials.gov Identifier:
NCT01890733
Other Study ID Numbers:
  • IS-CL-02
First Posted:
Jul 2, 2013
Last Update Posted:
Jun 4, 2020
Last Verified:
Sep 1, 2012
Keywords provided by OrthoSpace Ltd.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 4, 2020